Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

Contributed equally
BMC Cancer201818:5

https://doi.org/10.1186/s12885-017-3931-z

Received: 31 October 2016

Accepted: 18 December 2017

Published: 2 January 2018

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
31 Oct 2016 Submitted Original manuscript
10 Nov 2016 Author responded Author comments - Feifei Sun
Resubmission - Version 2
10 Nov 2016 Submitted Manuscript version 2
12 Dec 2016 Reviewed Reviewer Report - Craig Portell
13 Feb 2017 Author responded Author comments - Feifei Sun
Resubmission - Version 3
13 Feb 2017 Submitted Manuscript version 3
9 Apr 2017 Reviewed Reviewer Report - Hao Wang
11 Apr 2017 Reviewed Reviewer Report - Feng Gao
25 Aug 2017 Author responded Author comments - Feifei Sun
Resubmission - Version 4
25 Aug 2017 Submitted Manuscript version 4
29 Aug 2017 Reviewed Reviewer Report - Feng Gao
4 Sep 2017 Reviewed Reviewer Report - Hao Wang
7 Oct 2017 Author responded Author comments - Feifei Sun
Resubmission - Version 5
7 Oct 2017 Submitted Manuscript version 5
10 Oct 2017 Reviewed Reviewer Report - Hao Wang
25 Nov 2017 Author responded Author comments - Feifei Sun
Resubmission - Version 6
25 Nov 2017 Submitted Manuscript version 6
14 Dec 2017 Author responded Author comments - Feifei Sun
Resubmission - Version 7
14 Dec 2017 Submitted Manuscript version 7
Publishing
18 Dec 2017 Editorially accepted
2 Jan 2018 Article published 10.1186/s12885-017-3931-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
(2)
Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
(3)
Department of Biochemistry and Molecular Biology, Mayo Clinic Scottsdale, Scottsdale, USA

Advertisement